These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 23500060)

  • 1. On the efficacy of malaria DNA vaccination with magnetic gene vectors.
    Nawwab Al-Deen F; Ma C; Xiang SD; Selomulya C; Plebanski M; Coppel RL
    J Control Release; 2013 May; 168(1):10-7. PubMed ID: 23500060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superparamagnetic nanoparticles for effective delivery of malaria DNA vaccine.
    Al-Deen FN; Ho J; Selomulya C; Ma C; Coppel R
    Langmuir; 2011 Apr; 27(7):3703-12. PubMed ID: 21361304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nanoparticle coating on the immunogenicity of plasmid DNA vaccine encoding P. yoelii MSP-1 C-terminal.
    Shuaibu MN; Cherif MS; Kurosaki T; Helegbe GK; Kikuchi M; Yanagi T; Sasaki H; Hirayama K
    Vaccine; 2011 Apr; 29(17):3239-47. PubMed ID: 21354479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration.
    Cherif MS; Shuaibu MN; Kurosaki T; Helegbe GK; Kikuchi M; Yanagi T; Tsuboi T; Sasaki H; Hirayama K
    Vaccine; 2011 Nov; 29(48):9038-50. PubMed ID: 21939717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of magnetic polyplexes taken up efficiently by dendritic cell for enhanced DNA vaccine delivery.
    Nawwab Al-Deen FM; Selomulya C; Kong YY; Xiang SD; Ma C; Coppel RL; Plebanski M
    Gene Ther; 2014 Feb; 21(2):212-8. PubMed ID: 24352195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On designing stable magnetic vectors as carriers for malaria DNA vaccine.
    Al-Deen FN; Selomulya C; Williams T
    Colloids Surf B Biointerfaces; 2013 Feb; 102():492-503. PubMed ID: 23104020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous prime-boost regimen adenovector 35-circumsporozoite protein vaccine/recombinant Bacillus Calmette-Guérin expressing the Plasmodium falciparum circumsporozoite induces enhanced long-term memory immunity in BALB/c mice.
    Arama C; Assefaw-Redda Y; Rodriguez A; Fernández C; Corradin G; Kaufmann SH; Reece ST; Troye-Blomberg M
    Vaccine; 2012 Jun; 30(27):4040-5. PubMed ID: 22521849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A bicistronic DNA vaccine containing apical membrane antigen 1 and merozoite surface protein 4/5 can prime humoral and cellular immune responses and partially protect mice against virulent Plasmodium chabaudi adami DS malaria.
    Rainczuk A; Scorza T; Spithill TW; Smooker PM
    Infect Immun; 2004 Oct; 72(10):5565-73. PubMed ID: 15385453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites.
    Leitner WW; Seguin MC; Ballou WR; Seitz JP; Schultz AM; Sheehy MJ; Lyon JA
    J Immunol; 1997 Dec; 159(12):6112-9. PubMed ID: 9550412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
    Walsh DS; Gettayacamin M; Leitner WW; Lyon JA; Stewart VA; Marit G; Pichyangkul S; Gosi P; Tongtawe P; Kester KE; Holland CA; Kolodny N; Cohen J; Voss G; Ballou WR; Heppner DG
    Vaccine; 2006 May; 24(19):4167-78. PubMed ID: 16574282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.
    Rodríguez A; Mintardjo R; Tax D; Gillissen G; Custers J; Pau MG; Klap J; Santra S; Balachandran H; Letvin NL; Goudsmit J; Radosević K
    Vaccine; 2009 Oct; 27(44):6226-33. PubMed ID: 19686691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent systemic antibody responses and immunisation-associated changes in mice orally and nasally immunised with Lactococcus lactis expressing a malaria parasite protein.
    Moorthy SA; Yasawardena SG; Ramasamy R
    Vaccine; 2009 Aug; 27(36):4947-52. PubMed ID: 19545652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune response induced by a linear DNA vector: influence of dose, formulation and route of injection.
    Endmann A; Baden M; Weisermann E; Kapp K; Schroff M; Kleuss C; Wittig B; Juhls C
    Vaccine; 2010 May; 28(21):3642-9. PubMed ID: 20362204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of gp120-specific protective immune responses by genetic vaccination with linear polyethylenimine-plasmid complex.
    Garzón MR; Berraondo P; Crettaz J; Ochoa L; Vera M; Lasarte JJ; Vales A; Van Rooijen N; Ruiz J; Prieto J; Zulueta J; González-Aseguinolaza G
    Vaccine; 2005 Feb; 23(11):1384-92. PubMed ID: 15661387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy.
    Min J; Qu D; Li C; Song X; Zhao Q; Li XA; Yang Y; Liu Q; He S; Zhou H
    Vaccine; 2012 Aug; 30(38):5631-6. PubMed ID: 22789504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
    Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
    Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-based vaccines for malaria: a heterologous prime-boost immunisation strategy.
    Hill AV; Reece W; Gothard P; Moorthy V; Roberts M; Flanagan K; Plebanski M; Hannan C; Hu JT; Anderson R; Degano P; Schneider J; Prieur E; Sheu E; Gilbert SC
    Dev Biol (Basel); 2000; 104():171-9. PubMed ID: 11713817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
    Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA
    Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
    Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
    Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.